Antiepileptic Drug Discovery and Development: What Have We Learned and Where Are We Going?

по Gerlach, Aaron C., Krajewski, Jeffrey L.
Опубликовано 2010

Validation of ion channel targets

по Gerlach, Aaron C, Antonio, Brett M
Опубликовано в: Channels (Austin) (2015)

Personalized medicine: Vinpocetine to reverse effects of GABRB3 mutation

по Billakota, Santoshi, Andresen, J. Michael, Gay, Bryant C., Stewart, Gregory R., Fedorov, Nikolai B., Gerlach, Aaron C., Devinsky, Orrin
Опубликовано в: Epilepsia (2019)

TRPA1 ankyrin repeat six interacts with a small molecule inhibitor chemotype

по Tseng, Wei Chou, Pryde, David C., Yoger, Katrina E., Padilla, Karen M., Antonio, Brett M., Han, Seungil, Shanmugasundaram, Veerabahu, Gerlach, Aaron C.
Опубликовано в: Proc Natl Acad Sci U S A (2018)

Discovery of a Series of Indazole TRPA1 Antagonists

по Pryde, David C., Marron, Brian E., West, Christopher W., Reister, Steven, Amato, George, Yoger, Katrina, Antonio, Brett, Padilla, Karen, Cox, Peter J., Turner, Jamie, Warmus, Joseph S., Swain, Nigel A., Omoto, Kiyoyuki, Mahoney, John H., Gerlach, Aaron C.
Опубликовано в: ACS Med Chem Lett (2017)

A novel selective and orally bioavailable Na(v)1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability

по Payne, Claire Elizabeth, Brown, Adam R, Theile, Jonathon W, Loucif, Alexandre J C, Alexandrou, Aristos J, Fuller, Mathew D, Mahoney, John H, Antonio, Brett M, Gerlach, Aaron C, Printzenhoff, David M, Prime, Rebecca L, Stockbridge, Gillian, Kirkup, Anthony J, Bannon, Anthony W, England, Steve, Chapman, Mark L, Bagal, Sharan, Roeloffs, Rosemarie, Anand, Uma, Anand, Praveen, Bungay, Peter J, Kemp, Mark, Butt, Richard P, Stevens, Edward B
Опубликовано в: Br J Pharmacol (2015)